DPC to focus on technology improving lives of people with diabetes
Technology that is improving the lives of people with diabetes will take centre stage at this year’s DPC.
The conference, which returns as an in-person event at Olympia London on 10 and 11 November, includes a dedicated Technology and Innovation Zone, where the latest diabetes products will be showcased in conjunction with a series of talks and demonstrations about how such technology is put into practice and the impact it is having.
Product exhibitions include:
BlueDop
BlueDop detects vascular disease and offers a cuffless alternative to traditional ABpI tests. Delegates will have the opportunity to test the BlueDop Vascular Expert, a software system which converts a digital doppler signal into a blood pressure reading.
ARKRAY’S The Lab 001
The Lab 001 uses cutting-edge technology to provide HbA1c results in 90 seconds. This latest diabetes testing technology is now being supplied directly to the UK by Japanese company ARKRAY.
The Lab 001 uses capillary electrophoresis technology in a compact device, providing high-quality HbA1c results while dramatically reducing patients’ wait time. A fingerpick sample can be used for measurement and the electropherogram generated indicates the HbA1c value along with any clinically significant variants.
MySugarWatch
MySugarWatch is needle-free continuous glucose monitoring – every five minutes for type 2 diabetes. The MySugarWatch daily sensor sits on the skin, monitoring glucose levels in real time without repeated scanning, and avoiding repeated fingerprick tests at work. It allows people with diabetes to track their highs and lows, identify trends and monitor their time in range.
Academy
Academy is a free educational platform where healthcare professionals can increase their knowledge in diabetes technologies. It was developed by Glooko, a provider of diabetes digital health solutions, in collaboration with the Association of British Clinical Diabetologists (ABCD) and Diabetes Technology Network UK (DTN-UK), supported by major companies committed to improving diabetes care.
Academy focusses exclusively on diabetes healthtech, data management and remote patient monitoring (RPM), to help clinicians keep their knowledge base current and to increase training. Courses include continuous glucose monitoring, diabetes technology in pregnancy and self-monitoring blood glucose.
The Edge at DPC
The Edge at DPC offers companies the opportunity to showcase innovative products, services and new approaches to care.
Among the companies exhibiting are:
Healthy Team
The Healthy Team is a leadership development organisation providing sessions and programmes to clinicians in the NHS. The Healthy Team designs learning solutions for teams to learn and develop together, with pharma partners playing a key role in supporting these teams.
Spotlight-AQ
A web-based platform, Spotlight-AQ is designed to reduce healthcare professional burden by providing pre-clinic assessments and mapped resources to deliver patient-centred care. The pre-clinic assessment platform focusses out-patient consultations through rapid identification of patient priority concerns and how to meet them. Its algorithm customises the assessment for each patient, presenting a unique results page, facilitating collaborative care planning with a healthcare professional.
Technology and Innovation Zone
- As well as viewing the latest diabetes products, DPC delegates visiting the Technology and Innovation Zone will also be able to listen to relevant talks and demonstrations:
- NHS life-changing innovations – glucose monitoring, hybrid closed-loop system and treating monogenic diabetes
- Panel: ‘How important is interconnectivity of devices and systems for better patient management and outcomes?’
- The benefits of Pod Therapy: Today and future advancements
- Hybrid closed loop rollout
- Live demonstrations of the Omnipod DASH Insulin Management System
- Identifying and prioritising patients in primary care post pandemic
Professor Pratik Choudhary, professor of diabetes and honorary consultant and chair of Diabetes Technology Network UK (DTN-UK), is one of the speakers on a panel discussing ‘The Digital Divide: What can I do in my practice to improve access to diabetes technology?’, which will look at the different factors that affect access to technology.
He said: “These factors include the size of a clinical service where there’s a type 1 lead, but also social factors. We will consider how you can try to minimise any unconscious bias within your teams and help support the use of technology by the people who often need it the most but are least likely come forward and request it.”
DPC2021 is open to any healthcare professional involved in the prevention, treatment and management of diabetes and its related conditions.
The focus of this year’s event is ‘Rebooting Diabetes Care’ after the pandemic, reviewing the last two years and looking ahead to see how people living with diabetes and its related conditions can best be supported.